Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Gåbalansträning efter stroke

26 oktober 2026 uppdaterad av: Keith Gordon, Northwestern University

Rörelseförstärkningsträning för att förbättra gångbalansen efter stroke

Stroke is one of the leading causes of disability in the United States, affecting ~795,000 people annually. Among ambulatory people with chronic stroke, impaired balance is common and substantially limits mobility (those with the poorest balance walk the least). This project will explore if a novel gait training intervention using a robotic device to amplify a person's self-generated movements can improve walking balance in people with chronic stroke. The development of effective interventions to increase walking balance among people with chronic stroke will positively impact quality of life and ability to participate in walking activities.

Studieöversikt

Detaljerad beskrivning

Background: People with chronic stroke (PwCS) have substantial walking balance dysfunctions that limit independence and participation in walking activities. There is a pressing need to develop effective methods to enhance walking balance in PwCS. Interventions that amplify self-generated movements may accelerate motor learning by enhance a person's perception of movement errors. This method could potentially be applied to help PwCS improve walking balance. To this end, we have developed a cable-driven robot to create a Movement Amplification Environment (MAE) during treadmill walking. The MAE challenges walking balance by applying lateral forces to the pelvis that are proportional in magnitude to real-time lateral center of mass (COM) velocity. Our purpose is to evaluate effects of MAE training on walking balance in PwCS.

Specific Aims: Aim 1a: To quantify locomotor adaptations PwCS make to maintain walking balance in a MAE. We will evaluate the impact of the two foremost gait training variables: Gait Speed and MAE Strength. Aim 1b: To evaluate short-term changes in the ability of PwCS to control their lateral COM excursion during walking (a quantifiable walking balance measure) immediately after MAE training. Aim 2: To evaluate long-term changes in walking balance and daily walking following a 5-week high-intensity gait training intervention performed in a MAE.

Approach: Aims 1a & b: Twenty PwCS will each participate in two experiments evaluating gait biomechanics (COM dynamics and stepping patterns) during and immediately following MAE training. Aim 1a will evaluate locomotor adaptations when walking in a MAE and the effect of gait speed (slow, preferred, and fast) and MAE strength (low, medium, and high). Aim 1b will use visual feedback to challenge PwCS to control their lateral COM excursion during walking immediately before and after walking in different external conditions (No applied forces, or MAE). Outcomes will assess if short-term walking balance is enhanced immediately following MAE exposure. Aim 2: Ten PwCS will participate in 10-sessions of high intensity gait training performed in a MAE. We will assess pre- to post- changes in walking balance using clinical gait and balance measures, biomechanical assessments, and participation in daily walking (steps/day). Outcomes will assess if long-term walking balance is enhanced following MAE gait training.

Impact: Training walking balance of PwCS by amplifying their own self-generated movements is a radical departure from current practice and could substantially enhance walking balance. This study will provide a foundational understanding of how PwCS maintain walking balance in a MAE and if beneficial behaviors persist following MAE training. Successful outcomes will motivate a randomized controlled trial assessing efficacy of MAE training on walking balance in PwCS.

Studietyp

Interventionell

Inskrivning (Faktisk)

33

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Illinois
      • Chicago, Illinois, Förenta staterna, 60611
        • Northwestern University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 85 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. 18 to 80 years of age;
  2. diagnosis of hemiparetic stroke;
  3. more than 6 months post-stroke;
  4. ability to ambulate over ground for 10 meters with or without a single cane, and/or ankle-foot orthosis.

Exclusion Criteria:

  1. cognitive impairment (score of ≤22/30 on the Montreal Cognitive Assessment scale);
  2. aphasia (score of ≥71/100 on the Mississippi Aphasia Screening Test);
  3. excessive spasticity in lower limbs (score of > 3 on the Modified Ashworth Scale);
  4. unable to tolerate 10-min. of standing;
  5. enrollment in concurrent physical therapy;
  6. use of braces/orthotics crossing the knee joint;
  7. known pregnancy;
  8. severe cardiovascular, musculoskeletal, or other neurological conditions affecting gait and balance.
  9. brainstem and/or cerebellar lesion
  10. perinatal stroke

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Control of lateral COM motion during and after walking practiced in the MAE

For Aim 1a, participant's preferred and fast treadmill walking speeds will be determined followed by 2-min of baseline walking. Each participant will perform eight 2-min trials of treadmill walking 1) Null Environment: no forces, 2) MAE Low Gain: 25 Nsm-1, 3) MAE Medium Gain: 35 Nsm-1, 4) MAE High Gain: 45 Nsm-1, that will be repeated at both treadmill walking speeds. The trial order will be randomized.

For Aim 1b, we will assess participant's maximum ability to control their lateral COM motion with no forces applied, using three 21-meter walking trials with visual projections on the treadmill to provide feedback used to challenge their lateral COM motion control. Five 2-min trials in a Null environment will be followed by COM control assessment. Participants will rest and repeat the above sequence in a MAE. The order of the external environments will be randomized across participants.

Participants may participate in more than one aim (1a, 1b and 2).

For Aim 2, each participant will engage in ten 45-min high-intensity gait training sessions performed in a Movement Amplification Environment (MAE). Training sessions will occur 2x/week and led by a licensed Physical Therapist. The goal of each training session is to achieve 40-min of stepping practice within a targeted range of heart rate (HR) of 70 to 80% of estimated age-predicted HR max and perceived excursion (RPE) in a MAE. Each session will begin and end with a 2.5-min warm-up and cool down, with 40-min of training using two 10-min Speed-training blocks and two 10-min Balance-training blocks. Balance training activities will include lateral maneuvers, head turns, obstacle negotiation, and backward walking. The MAE gain, training speeds and balance activities will be progressively increased within and across sessions to challenge the participant.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Gait Stability (Short-term Lyapunov Exponent)
Tidsram: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Gait stability was measured using the short-term Lyapunov exponent that quantifies the average logarithmic rate of divergence of a system after small kinematic deviations. This metric has demonstrated construct and predictive validity in prior simulation and walking studies where divergence is respective to the gait cycle. The lateral COM velocity (VCOM) was used for this calculation as a measure of local, dynamic stability. Lower values of the short-term Lyapunov exponent indicates higher stability and higher values indicates lower stability and greater challenge to walking balance. For Aim 1a, gait stability was calculated at session 1 (baseline). For Aim 1b, gait stability was calculated at session 2 and 3. For Aim 2, gait stability was calculated at session 4 (pre-training) and session 15 (post-training).

Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Lateral Center of Mass (COM) Excursion
Tidsram: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Lateral center of mass (COM) excursion occurring during 5 consecutive gait cycles was calculated as our metric of ability to control lateral COM motion during walking. Kinematic marker data was processed using Visual3D (C-Motion, Germantown, MD) and a custom MATLAB (Mathworks, Natick, MA) program. Marker data was gap-filled and low-pass filtered (Butterworth, 6 Hz cut-off frequency). Time of initial foot contact (IC) and toe-off (TO) events were identified for each step based on fore-aft positions of the calcaneus and 2nd metatarsal markers. A reduction in the mean lateral COM excursion suggests improved walking balance or adaptive response towards changing gains. For Aim 1a, COM excursion was calculated at session 1. For Aim 1b, gait stability was calculated at session 2 and 3. For Aim 2, COM excursion was calculated at session 4 (pre-training) and session 15 (post-training).

Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Lateral Center of Mass (COM) Velocity
Tidsram: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Lateral center of mass (COM) velocity was calculated by taking the derivative of filtered COM position (same filter as marker data). The average of absolute value of lateral COM velocity peaks in both directions were calculated. For Aim 1a, COM velocity was calculated at session 1. For Aim 1b, velocity was calculated at session 2 and 3. For Aim 2, COM velocity was calculated at session 4 (pre-training) and session 15 (post-training).

Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Ten Minute Walk Test (10MWT) at Preferred Speed
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Ten minute walk test (10MWT) is a simple measurement of an individual's average walking speed measured at self-selected speed (instruction: "walk at your normal comfortable pace"). For Aim 2, 10MWT was collected at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Ten Minute Walk Test (10MWT) at Fast Speed
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Ten minute walk test (10MWT) is a simple measurement of an individual's average walking speed measured at fast speed (instruction: "walk as fast as you can safely walk"). For Aim 2, 10MWT was collected at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Dynamic Gait Index (DGI)
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

DGI is a clinical assessment tool used to evaluate an individual's balance, walking ability, and fall risk. It tests how well a person can adapt their gait to external demands, such as navigating obstacles and turning their head, rather than just walking on a flat surface. Each task is graded on a 4-point ordinal scale (0 to 3), where 3 indicates normal function with no impairments, and 0 indicates severe impairment (e.g., losing balance or requiring physical assistance). The total score of DGI is 24, with a minimum score of 0 and maximum score of 24. Higher scores indicate better balance, while lower scores indicate poor balance. For Aim 2, DGI was calculated at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Berg Balance Scale (BBS)
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

BBS is a 14-item measure that assesses static balance with excellent validity and reliability in individuals post-stroke. The total score for this test is 56. Minimum score is 0 and maximum score is 56. Higher scores indicate better balance and lower fall-risk, while lower scores indicate poor balance and increased fall-risk. For Aim 2, BBS was calculated at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Timed up and go Test (TUG)
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

TUG was used to assess functional mobility, walking balance, and fall risk. It is a quick, valid, reliable and widely used clinical performance based measure in individuals post-stroke. While there is no time limit to the TUG test, more time taken to finish the task indicates poor balance and greater fall-risk. For Aim 2, TUG was calculated at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Activities-specific Balance Confidence (ABC) Scale
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

ABC scale is a self-reported measure of an individual's confidence while performing specific postural and ambulatory activities. The ABC is a reliable and valid measure of balance confidence in individuals post-stroke. The total score for ABC scale is 100. Minimum score is 0 and maximum score is 100. Higher scores indicate better balance confidence, while lower scores indicate poor balance confidence. For Aim 2, ABC scale was calculated at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Six Minute Walk Distance (6MWD)
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Six minute walk test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered during 6 minutes of walking indicate participants exercise tolerance. The vitals measures before and after the 6MWT indicate the cardiovascular and respiratory response to exercise. For Aim 2, 6MWD was collected at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Daily Stepping in the Home and Community
Tidsram: Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

The amount of daily stepping in the home and community taken per day averaged across the 7-day collection periods was collected before and after 10 high intensity gait training session in MAE in Aim 2. Daily stepping was measured and recorded using a StepWatch4 (Modus, Edmonds, WA) activity monitor. The microprocessor-based accelerometer was worn around the ankle during all waking hours (except bathing) for the duration of the stepping assessment period. For Aim 2, daily stepping was calculated at session 4 (pre-training) and session 15 (post-training).

Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Step Width
Tidsram: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Step width was calculated as the medio-lateral distance between the left and right 5th Metatarsal markers at initial foot contact. For Aim 1a, step width was calculated at session 1. For Aim 1b, step width was calculated at session 2 and 3.

Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.
Step Length
Tidsram: Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Step length was calculated as the anteroposterior distance between the calcaneal markers of the leading and trailing limbs at heel strike for each stride. For Aim 1a, step length was calculated at session 1. For Aim 1b, step length was calculated at session 2 and 3.

Session 1 was baseline; Sessions 2 and 3 occurred one week apart within 2 weeks to 10 months of baseline. Pre-training assessment (Session 4) occurred one year after baseline, and post-training assessment (Session 15) followed five weeks later.

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Keith Gordon, PhD, Assistant Professor, Northwestern University

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

18 augusti 2023

Primärt slutförande (Faktisk)

2 maj 2025

Avslutad studie (Faktisk)

2 maj 2026

Studieregistreringsdatum

Först inskickad

18 september 2023

Först inskickad som uppfyllde QC-kriterierna

17 oktober 2023

Första postat (Faktisk)

19 oktober 2023

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

18 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

26 oktober 2026

Senast verifierad

1 oktober 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • 1R21HD112813-01 (U.S.S. NIH-anslag/kontrakt)

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

JA

IPD-planbeskrivning

De-identified data from this study will be uploaded on the Northwestern University Research and Data repository (Arch) so that it is fully available to other parties interested in probing the data further and performing secondary analyses.

Tidsram för IPD-delning

After completion of the study

Kriterier för IPD Sharing Access

Data will be publicly available.

IPD-delning som stöder informationstyp

  • STUDY_PROTOCOL

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera